Rakesh Mulraj Vohra

Title: Rakesh Mulraj Vohra: Innovator in Immunosuppressive Agents

Introduction

Rakesh Mulraj Vohra is a notable inventor based in Chandigarh, India. He has made significant contributions to the field of immunology through his innovative research and patents. His work focuses on the development of bioactive molecules that can serve as effective immunosuppressive agents.

Latest Patents

Rakesh Mulraj Vohra holds a patent for the use of bipyridine compound 'Caerulomycin A' derivatives and analogs as immunosuppressive agents. The patent describes an isolated bioactive molecule, Caerulomycin A, which has shown effectiveness in targeting lymphocytes, CD4T cells, CD8T cells, and B cells. The compound operates by downregulating the expression of the activation marker CD28 while upregulating the immunosuppressive marker CTLA-4. This discovery highlights the immunomodulatory activity of Caerulomycin A, which was previously known for its antifungal properties.

Career Highlights

Rakesh Mulraj Vohra is associated with the Council of Scientific and Industrial Research, where he continues to advance his research in immunology. His work has garnered attention for its potential applications in medical science, particularly in the development of therapies for autoimmune diseases.

Collaborations

He has collaborated with notable colleagues such as Arvind Kumar Singla and Javed Naim Agrewala, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Rakesh Mulraj Vohra's contributions to the field of immunology through his patent on Caerulomycin A derivatives exemplify the impact of innovative research on medical science. His work not only advances our understanding of immunosuppressive agents but also opens new avenues for therapeutic applications.